Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer ...
Researchers developed a 220-sample pan-cancer patient-derived organoid platform that faithfully mirrors tumors and may ...
Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results